- Report
- January 2022
- 60 Pages
Global
From €3769EUR$3,950USD£3,157GBP
- Report
- June 2022
- 114 Pages
Global
From €4532EUR$4,750USD£3,796GBP
- Report
- October 2023
- 145 Pages
Global
From €3005EUR$3,150USD£2,518GBP
- Report
- June 2022
- 946 Pages
Global
From €2385EUR$2,500USD£1,998GBP
- Report
- August 2022
United States
From €1851EUR$1,940USD£1,551GBP
- Report
- August 2022
Global
From €1135EUR$1,190USD£951GBP
- Drug Pipelines
- November 2020
- 3809 Pages
Global
From €2385EUR$2,500USD£1,998GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €9536EUR$9,995USD£7,988GBP
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
China
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
France
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Germany
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
India
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Japan
From €1431EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Poland
From €1431EUR$1,500USD£1,199GBP
The Melanoma Drug market is a subset of the larger Skin Cancer Drugs market. It is composed of drugs used to treat melanoma, a type of skin cancer. These drugs are typically used in combination with other treatments such as surgery, radiation, and immunotherapy. Commonly used drugs include targeted therapies, immunotherapies, and chemotherapy. Targeted therapies are designed to target specific molecules in the cancer cells, while immunotherapies are designed to boost the body's own immune system to fight the cancer. Chemotherapy is used to kill cancer cells.
The Melanoma Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Roche, Novartis, and Pfizer. Other companies include AstraZeneca, Eli Lilly, and GlaxoSmithKline. Show Less Read more